IGC Pharma (IGC) Free Cash Flow Growth (5y) (2015 - 2025)
IGC Pharma (IGC) Free Cash Flow Growth (5y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
IGC Pharma |
28.11 Mn |
27.85 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
5.06% |
| Jun 30, 2025 |
22.10% |
| Mar 31, 2025 |
22.68% |
| Dec 31, 2024 |
19.05% |
| Sep 30, 2024 |
15.98% |
| Jun 30, 2024 |
15.05% |
| Mar 31, 2024 |
14.09% |
| Dec 31, 2023 |
-4.39% |
| Sep 30, 2023 |
-39.22% |
| Jun 30, 2023 |
-22.56% |
| Mar 31, 2023 |
-7.04% |
| Dec 31, 2022 |
-44.99% |
| Sep 30, 2022 |
-63.35% |
| Jun 30, 2022 |
-34.60% |
| Mar 31, 2022 |
1.62% |
| Dec 31, 2021 |
-71.06% |
| Sep 30, 2021 |
-21.64% |
| Jun 30, 2021 |
-63.63% |
| Mar 31, 2021 |
-74.13% |
| Dec 31, 2020 |
-107.65% |
